Send us Feedback

Sucampo Pharmaceuticals (SCMP)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Sucampo Pharmaceuticals Receives Orphan Designation from EU for Unoprostone Isopropyl for Treatment of Retinitis Pigmentosa
Benzinga  May 29  Comment 
Sucampo Pharmaceuticals, Inc. (“Sucampo”) (NASDAQ: SCMP), a global biopharmaceutical company, today announced that it has received orphan drug designation in the European Union for unoprostone isopropyl for the treatment...
Sucampo's (SCMP) Unoprostone Isopropyl Receives Orphan Drug Designation as RP Treatment
StreetInsider.com  May 29  Comment 
Sucampo Pharmaceuticals Announces FDA Approves Supplemental for AMITIZA
Benzinga  Apr 23  Comment 
Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI) and Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) announced today that the United States (U.S.) Food and Drug Administration (FDA) has approved Sucampo's supplemental new drug...
Sucampo Pharma (SCMP) sNDA for AMITIZA Receives FDA Approval
StreetInsider.com  Apr 23  Comment 
Sucampo Wins Approval for Expanded Use of Amitiza in U.S.
Bloomberg  Apr 23  Comment 
UPDATE: Cantor Fitzgerald Initiates Sucampo Pharmaceuticals with Buy Rating on Near-Term Excitement, Long-Term Value
Benzinga  Apr 3  Comment 
In a report published Wednesday, Cantor Fitzgerald analyst Irina Rivkind initiated coverage on Sucampo Pharmaceuticals (NASDAQ: SCMP) with a Buy rating and $9.00 price target. In the report, Rivkind noted, “Sucampo is a closely held...
Benzinga's Top Initiations
Benzinga  Apr 3  Comment 
Sucampo Pharmaceuticals, Christopher & Banks Announce Earnings
Forbes  Mar 14  Comment 
Sucampo Pharmaceuticals (SCMP) announced that earnings increased to $13.5 million, or 32 cents per share, up from $2.7 million, or 6 cents per share. Revenue increased to $34.9 million from $14.2 million, while research and development revenue...
Sucampo Pharmaceuticals, Inc. (SCMP) Tops Q4 EPS by 20c
StreetInsider.com  Mar 13  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Sucampo+Pharmaceuticals%2C+Inc.+%28SCMP%29+Tops+Q4+EPS+by+20c/8183139.html for the full story.
Sucampo Announces RESCULA is Now Available by Prescription Across the US
Benzinga  Feb 20  Comment 
Sucampo Pharmaceuticals (NASDAQ: SCMP) (SPI) today announced that RESCULA (unoprostone isopropyl ophthalmic solution) 0.15% is now available by prescription across the United States. The U.S. Food and Drug Administration (FDA) ...
Sucampo Pharma (SCMP) Reports Adoption of Unoprostone Isopropyl by JST
StreetInsider.com  Feb 4  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Sucampo+Pharma+%28SCMP%29+Reports+Adoption+of+Unoprostone+Isopropyl+by+JST/8053752.html for the full story.
Sucampo Pharma (SCMP) Files $150M Mixed Shelf
StreetInsider.com  Dec 21  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Sucampo+Pharma+%28SCMP%29+Files+%24150M+Mixed+Shelf/7967640.html for the full story.




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


You may also be interested in articles related to Sucampo Pharmaceuticals (SCMP):
 




References

Retrieved from "http://www.wikinvest.com/stock/Sucampo_Pharmaceuticals_(SCMP)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki